We are live on ! Find out more
BOS

Bingham Osborn & Scarborough Portfolio holdings

AUM $1.42B
1-Year Est. Return 27.88%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+27.88%
3 Year Est. Return
+51.71%
5 Year Est. Return
+102.3%
10 Year Est. Return
AUM
$1.1B
AUM Growth
+$30.2M
Cap. Flow
-$29M
Cap. Flow %
-2.64%
Top 10 Hldgs %
83.6%
Holding
135
New
13
Increased
47
Reduced
50
Closed
4

Top Buys

Rank Stock Value
1
APH icon
Amphenol
APH
+$7.04M
2
PG icon
Procter & Gamble
PG
+$1.36M
3
ABBV icon
AbbVie
ABBV
+$962K
4
BAC icon
Bank of America
BAC
+$837K
5
FTS icon
Fortis
FTS
+$679K

Sector Composition

Rank Sector Weight
1 Technology 4.25%
2 Financials 2.33%
3 Consumer Staples 1.57%
4 Industrials 1.49%
5 Consumer Discretionary 1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
101
Merck
MRK
$316B
$321K 0.03%
5,987
-678
-10% -$37.6K
HAP icon
102
VanEck Natural Resources ETF
HAP
$300M
$316K 0.03%
8,500
BSV icon
103
Vanguard Short-Term Bond ETF
BSV
$44.6B
$315K 0.03%
3,980
BEN icon
104
Franklin Resources
BEN
$18.3B
$312K 0.03%
7,193
-695
-9% -$30.1K
EEM icon
105
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$312K 0.03%
6,625
-1,795
-21% -$83.1K
AGG icon
106
iShares Core US Aggregate Bond ETF
AGG
$137B
$311K 0.03%
2,843
-969
-25% -$106K
CSX icon
107
CSX Corp
CSX
$92.3B
$310K 0.03%
16,908
-45
-0.3% -$797
DOV icon
108
Dover
DOV
$27.7B
$304K 0.03%
3,726
SUSA icon
109
iShares ESG Optimized MSCI USA ETF
SUSA
$4.08B
$299K 0.03%
5,382
PEY icon
110
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.15B
$276K 0.03%
+15,500
New +$271K
KO icon
111
Coca-Cola
KO
$374B
$260K 0.02%
5,672
+639
+13% +$29.4K
TGT icon
112
Target
TGT
$67.8B
$257K 0.02%
3,934
-3,077
-44% -$186K
MDY icon
113
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
$245K 0.02%
709
-367
-34% -$124K
IWV icon
114
iShares Russell 3000 ETF
IWV
$19.9B
$241K 0.02%
1,526
+1
+0.1% +$154
AXP icon
115
American Express
AXP
$233B
$239K 0.02%
2,411
-18
-0.7% -$1.71K
VYM icon
116
Vanguard High Dividend Yield ETF
VYM
$81.4B
$231K 0.02%
+2,695
New +$225K
UL icon
117
Unilever
UL
$137B
$225K 0.02%
3,619
-21
-0.6% -$1.33K
UNH icon
118
UnitedHealth
UNH
$377B
$224K 0.02%
+1,016
New +$215K
NEE icon
119
NextEra Energy
NEE
$181B
$222K 0.02%
+5,696
New +$220K
ADI icon
120
Analog Devices
ADI
$176B
$220K 0.02%
+2,473
New +$219K
DON icon
121
WisdomTree US MidCap Dividend Fund
DON
$4.06B
$215K 0.02%
+6,093
New +$208K
OKE icon
122
Oneok
OKE
$55.6B
$213K 0.02%
3,983
-170
-4% -$9.07K
XBI icon
123
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$212K 0.02%
2,500
PBCT
124
DELISTED
People's United Financial Inc
PBCT
$207K 0.02%
11,072
+90
+0.8% +$1.67K
CW icon
125
Curtiss-Wright
CW
$27.6B
$206K 0.02%
1,693
-430
-20% -$50.7K

Similar funds

Bingham Osborn & Scarborough's Q4 2017 Portfolio in Review

As of Q4 2017, Bingham Osborn & Scarborough held 135 positions worth $1.1B, up 2.8% from $1.07B the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Bingham Osborn & Scarborough's Q4 2017 filing shows 13 new, 47 increased, 50 reduced and 4 closed positions. Its largest new stake was Fortis: 18,404 shares worth $675K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $18.7M.

By sector, the portfolio is most concentrated in Technology at 4.3% of assets, up from 3.5% a quarter earlier, followed by Financials and Consumer Staples.

  • Bingham Osborn & Scarborough's largest Q4 2017 buy was Fortis: 18,404 shares worth $675K.
  • Bingham Osborn & Scarborough added most to Amphenol in Q4 2017, an estimated $7.04M increase.
  • Bingham Osborn & Scarborough's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $18.7M.
  • Bingham Osborn & Scarborough fully exited Ross Stores in Q4 2017, selling an estimated $538K.
  • Bingham Osborn & Scarborough's ten largest holdings make up 84% of its $1.1B portfolio in Q4 2017.
  • Bingham Osborn & Scarborough opened 13 new positions and closed 4 in Q4 2017.
  • Bingham Osborn & Scarborough's portfolio value rose 2.8% quarter-over-quarter to $1.1B.

Based on Bingham Osborn & Scarborough's 13F filing for Q4 2017, filed 25 Jan 2018.